Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Als Tandpleje I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   10.2% 9.0% 9.2% 9.3% 9.9% 9.9% 14.3% 14.3%   Credit score (0-100)   25 28 26 25 24 24 15 15   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,105 5,678 5,712 5,163 4,643 4,986 0.0 0.0   EBITDA   2,870 2,894 2,702 2,154 1,665 1,827 0.0 0.0   EBIT   2,870 2,894 2,702 2,154 1,665 1,827 0.0 0.0   Pre-tax profit (PTP)   2,880.9 2,896.3 2,702.0 2,152.5 1,666.7 1,827.9 0.0 0.0   Net earnings   2,880.9 2,896.3 2,702.0 2,152.5 1,666.7 1,827.9 0.0 0.0   Pre-tax profit without non-rec. items   2,881 2,896 2,702 2,152 1,667 1,828 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -168 -88.6 -110 226 56.6 98.7 0.0 0.0   Interest-bearing liabilities   0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0   Balance sheet total (assets)   443 612 474 475 339 448 0.0 0.0   Net Debt   -141 -312 -200 -186 2.6 -131 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,105 5,678 5,712 5,163 4,643 4,986 0.0 0.0   Gross profit growth   0.0% -7.0% 0.6% -9.6% -10.1% 7.4% -100.0% 0.0%   Employees   10 10 10 10 9 9 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -10.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   443 612 474 475 339 448 0 0   Balance sheet change%   0.0% 38.2% -22.5% 0.1% -28.6% 32.3% -100.0% 0.0%   Added value   2,870.3 2,894.5 2,701.5 2,154.0 1,665.0 1,826.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 38 -202 262 -199 231 -130   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   47.0% 51.0% 47.3% 41.7% 35.9% 36.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   472.2% 442.3% 421.2% 407.7% 409.9% 464.5% 0.0% 0.0%   ROI %   0.0% 3,726.6% 3,477.5% 1,912.8% 1,121.5% 2,145.9% 0.0% 0.0%   ROE %   651.0% 549.5% 497.8% 615.4% 1,181.4% 2,353.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -27.6% -12.7% -18.8% 48.3% 17.0% 22.0% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -4.9% -10.8% -7.4% -8.6% 0.2% -7.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 26.7% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 5.4% 11.7% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.6 1.0 0.7 1.7 1.0 1.1 0.0 0.0   Current Ratio   0.7 1.1 0.8 1.9 1.2 1.3 0.0 0.0   Cash and cash equivalent   140.7 312.1 200.3 185.7 12.5 131.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -167.5 66.9 -109.6 225.5 56.6 98.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   287 289 270 215 185 203 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   287 289 270 215 185 203 0 0   EBIT / employee   287 289 270 215 185 203 0 0   Net earnings / employee   288 290 270 215 185 203 0 0